Lung Cancer

New results appear to undercut the longstanding notion that individuals who smoke menthol cigarettes have a higher risk of lung cancer than those who smoke nonmenthol cigarettes

Dr Paz-Ares from Seville University Hospital Discusses Pemetrexed Clinical Trial

Primary cancers of the lung, esophagus, and pancreas-all of which have a poor prognosis-account for >35% of all cancer deaths in the United States annually

Patients with node-negative, locally advanced lung tumors who undergo induction chemoradiotherapy appear to survive significantly longer than patients who undergo surgical resection without induction chemoradiotherapy

Continuation maintenance with pemetrexed (Alimta) improves progression-free survival in patients with advanced nonsquamous non–small cell lung cancer

Dr. Kris From Memorial Sloan-Kettering Cancer Center on the Use of Genetic Testing in Lung Cancer

Taking a page from breast cancer treatment, clinicians managing lung cancer patients can now detect mutations that drive the development of lung cancer

A Canadian study has found that a daily fish oil supplement can thwart chemotherapy-induced muscle and weight loss in lung cancer patients

Each year the National Comprehensive Cancer Network (NCCN) presents the latest updates to its Clinical Practice Guidelines in Oncology, as well as the latest cancer therapies by key opinion leaders.

Crizotinib was accepted for filing by the FDA and granted Priority Review status

ASTRO has for the first time issued its own extensive guidelines for the use of palliative thoracic radiotherapy in patients with metastatic lung cancer

The chorus of support is growing among oncology experts for routine genetic testing of tumors from patients with advanced non-small cell lung cancer

Negative attitudes toward smokers extend to patients with lung cancer, regardless of whether or not they have ever actually smoked

The march toward personalized cancer care may have taken a step forward with the discovery of a potential biomarker

Lung cancer in nonsmokers may soon have an adjunctive blood test for revealing common biomarkers

For the first time in at least 3 decades, the rate of women dying from lung cancer in the United States is declining

Mark G. Kris, MD. Chief, Thoracic Oncology Service at Memorial Sloan-Kettering Cancer Center in New York on the EML4-ALK Translocation

Contrary to the conventional wisdom, mentholated cigarette smokers are less likely to develop lung cancer

Dr. Mark G. Kris from Memorial Sloan-Kettering Cancer Center on the Crizotinib Clinical Trials

Dr. Mark G. Kris from Memorial Sloan-Kettering on Caring for Elderly Lung Cancer Patients

Mark G. Kris, MD. Chief, Thoracic Oncology Service at Memorial Sloan-Kettering Cancer Center in New York Discusses EGFR Mutation Testing

The National Lung Screening Trial (NLST), a randomized, national trial involving 53,000 current and former heavy smokers, compared the effects of 2 screening procedures for lung cancer

The ravages of lung cancer due to cigarette smoking are all too familiar to oncology healthcare providers.

The search for a screening tool that can help detect lung cancers at early stages has been a focus of research aimed at the leading cause of cancer death in the United States.

Useful Online Resources and Clinical Trials for Lung Cancer